🌎 Insulet Downgraded, Saia Downgraded, ConocoPhillips Downgraded and more…
RJ Hamster
Advertisements
Ratings changes for Mobileye Global, U.S. Global Investors, Evoke Pharma, TherapeuticsMD, BIOLASE, Key Tronic, NeuroMetrix and more…Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial.
May 1st: The Day That Could Change Everything (ad)
This may be one of the only profitable companies with Bitcoin infrastructure — real revenue, real momentum — that is publicly traded.
The company generated over $144 million in revenue last year (top line for 2024) and $80.4 million in EBITDA — and it’s still not listed on a senior exchange.
Arista Networks (NYSE:ANET) was upgraded by analysts at Rosenblatt Securities from a “sell” rating to a “neutral” rating. They now have a $85.00 price target on the stock, up previously from $55.00. This represents a 6.2% upside from the current price of $80.01.
Chord Energy (NASDAQ:CHRD) was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $114.00 price target on the stock. This represents a 21.9% upside from the current price of $93.49.
Crane (NYSE:CR) was upgraded by analysts at UBS Group AG from a “neutral” rating to a “buy” rating. They now have a $190.00 price target on the stock, up previously from $157.00. This represents a 18.3% upside from the current price of $160.67.
Diamondback Energy (NASDAQ:FANG) was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $170.00 price target on the stock. This represents a 25.0% upside from the current price of $136.00.
Upstart (NASDAQ:UPST) was upgraded by analysts at Bank of America Co. from an “underperform” rating to a “neutral” rating. They now have a $53.00 price target on the stock. This represents a 5.4% upside from the current price of $50.30.
The AI Stocks Under $15 You Don’t Want to Miss in 2025 (ad)
AI Is Changing Everything—These 2 Stocks Could Lead the Charge
From healthcare to finance, AI is driving a new wave of innovation. But while the biggest names grab headlines, the smartest opportunities may be elsewhere. This report highlights two undervalued AI stocks trading under $15—companies with real potential as the AI race accelerates in 2025.
L’Air Liquide (OTCMKTS:AIQUY) was downgraded by analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating.The current price is $40.72.
Avantor (NYSE:AVTR) was downgraded by analysts at The Goldman Sachs Group, Inc. from a “buy” rating to a “neutral” rating. They now have a $14.00 price target on the stock, down previously from $23.00. This represents a 13.2% upside from the current price of $12.36.
Builders FirstSource (NYSE:BLDR) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating. They now have a $125.00 price target on the stock, down previously from $156.00. This represents a 3.8% upside from the current price of $120.41.
ConocoPhillips (NYSE:COP) was downgraded by analysts at Bank of America Co. from a “buy” rating to a “neutral” rating. They now have a $107.00 price target on the stock. This represents a 17.4% upside from the current price of $91.13.
Hims & Hers Health (NYSE:HIMS) was downgraded by analysts at TD Cowen from a “buy” rating to a “hold” rating. They now have a $30.00 price target on the stock, down previously from $44.00. This represents a 16.4% downside from the current price of $35.90.
ICON Public (NASDAQ:ICLR) was downgraded by analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating. They now have a $150.00 price target on the stock, down previously from $265.00. This represents a 4.0% upside from the current price of $144.26.
InMode (NASDAQ:INMD) was downgraded by analysts at BTIG Research from a “buy” rating to a “neutral” rating.The current price is $13.97.
Lufax (NYSE:LU) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a “hold” rating to a “sell” rating.The current price is $2.90.
LVMH Moët Hennessy – Louis Vuitton, Société Européenne (OTCMKTS:LVMUY) was downgraded by analysts at BNP Paribas from an “outperform” rating to a “neutral” rating.The current price is $114.15.
National Grid (NYSE:NGG) was downgraded by analysts at UBS Group AG from a “buy” rating to a “neutral” rating.The current price is $73.07.
Insulet (NASDAQ:PODD) was downgraded by analysts at Wolfe Research from an “outperform” rating to a “peer perform” rating.The current price is $254.20.
Saia (NASDAQ:SAIA) was downgraded by analysts at Stephens from an “overweight” rating to an “equal weight” rating. They now have a $255.00 price target on the stock, down previously from $515.00. This represents a 10.9% upside from the current price of $230.03.
Controladora Vuela Compañía de Aviación (NYSE:VLRS) was downgraded by analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating. They now have a $4.40 price target on the stock. This represents a 20.7% upside from the current price of $3.65.
Controladora Vuela Compañía de Aviación (NYSE:VLRS) was downgraded by analysts at Barclays PLC from an “overweight” rating to an “equal weight” rating. They now have a $4.50 price target on the stock, down previously from $12.00. This represents a 23.5% upside from the current price of $3.65.
Abacus Life (NASDAQ:ABL) is now covered by analysts at Maxim Group. They set a “buy” rating and a $14.00 price target on the stock. This represents a 73.2% upside from the current price of $8.09.
Autonomix Medical (NASDAQ:AMIX) is now covered by analysts at Maxim Group. They set a “buy” rating and a $5.00 price target on the stock. This represents a 92.9% upside from the current price of $2.59.
Apellis Pharmaceuticals (NASDAQ:APLS) is now covered by analysts at Cantor Fitzgerald. They set an “overweight” rating and a $44.00 price target on the stock. This represents a 144.2% upside from the current price of $18.02.
BioCryst Pharmaceuticals (NASDAQ:BCRX) is now covered by analysts at Cantor Fitzgerald. They set an “overweight” rating and a $20.00 price target on the stock. This represents a 135.6% upside from the current price of $8.49.
Diversified Energy (NYSE:DEC) is now covered by analysts at Citigroup Inc.. They set a “buy” rating and a $16.00 price target on the stock. This represents a 26.2% upside from the current price of $12.68.
Viant Technology (NASDAQ:DSP) is now covered by analysts at Rosenblatt Securities. They set a “buy” rating and a $20.00 price target on the stock. This represents a 36.4% upside from the current price of $14.66.
InflaRx (NASDAQ:IFRX) is now covered by analysts at Cantor Fitzgerald. They set an “overweight” rating and a $10.00 price target on the stock. This represents a 663.4% upside from the current price of $1.31.
Kinetik (NASDAQ:KNTK) is now covered by analysts at UBS Group AG. They set a “neutral” rating and a $49.00 price target on the stock. This represents a 14.3% upside from the current price of $42.88.
Magnite (NASDAQ:MGNI) is now covered by analysts at Rosenblatt Securities. They set a “buy” rating and a $18.00 price target on the stock. This represents a 45.0% upside from the current price of $12.41.
Strategy (NASDAQ:MSTR) is now covered by analysts at HC Wainwright. They set a “buy” rating and a $480.00 price target on the stock. This represents a 27.9% upside from the current price of $375.18.
Nexxen International (NASDAQ:NEXN) is now covered by analysts at Rosenblatt Securities. They set a “buy” rating and a $15.00 price target on the stock. This represents a 53.4% upside from the current price of $9.78.
Pharvaris (NASDAQ:PHVS) is now covered by analysts at Cantor Fitzgerald. They set an “overweight” rating and a $28.00 price target on the stock. This represents a 60.0% upside from the current price of $17.50.
ProQR Therapeutics (NASDAQ:PRQR) is now covered by analysts at Evercore ISI. They set an “outperform” rating and a $5.00 price target on the stock. This represents a 205.8% upside from the current price of $1.64.
ProQR Therapeutics (NASDAQ:PRQR) is now covered by analysts at Cantor Fitzgerald. They set an “overweight” rating and a $8.00 price target on the stock. This represents a 389.3% upside from the current price of $1.64.
Trade Desk (NASDAQ:TTD) is now covered by analysts at Rosenblatt Securities. They set a “buy” rating and a $77.00 price target on the stock. This represents a 40.4% upside from the current price of $54.85.
Wave Life Sciences (NASDAQ:WVE) is now covered by analysts at Cantor Fitzgerald. They set an “overweight” rating and a $10.00 price target on the stock. This represents a 45.6% upside from the current price of $6.87.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
